---
permalink: /
title: "Welcome to Hao Liu‚Äôs homepage!"
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---

About Me
======
ÂàòÊòä  
Hao, Liu

I am a Ph.D. candidate in Pharmacokinetics and Drug Metabolism at the State Key Laboratory of Natural Medicines, China Pharmaceutical University, working at the intersection of computational pharmacology and artificial intelligence. My research focuses on applying advanced machine learning techniques to drug discovery, particularly for challenging therapeutic targets, and developing AI-driven approaches for pharmacokinetic modeling and clinical decision support. I am fortunate to be supervised by Academician [Guangji Wang](https://www.cae.cn/cae/html/main/colys/41733597.html) and Professor [Guo Yu](https://ygl.cpu.edu.cn/gmis5/dsfc/dsfcgrxx/D505D9EA25B7E8E3FCA77DEC1F03C908) from China Pharmaceutical University, and Professor [De-chuan Zhan](https://www.yuque.com/zhandc/home/nk8z4o) from the School of Artificial Intelligence, Nanjing University.

**Contact**: [3124074362@stu.cpu.edu.cn](mailto:3124074362@stu.cpu.edu.cn) | **Location**: A202, Yifu Building, Nanjing University Xianlin Campus

---

## üî¨ Research Interests

My research bridges computational methods and pharmaceutical applications, with emphasis on:

**Primary Focus: AI-Driven Drug Discovery for Challenging Targets**
- Computational design and optimization of therapeutic peptides (antimicrobial peptides, cell-penetrating peptides)
- Integration of multimodal deep learning, reinforcement learning, and evolutionary algorithms
- Multi-objective optimization for drug-like properties (efficacy, safety, pharmacokinetics)
- Generative models for novel molecular design

**Clinical Machine Learning Applications**
- Interpretable deep learning models for clinical risk prediction
- Dynamic prediction systems for postoperative complications
- Frailty assessment and geriatric care optimization
- Mental health risk stratification (postpartum depression, perioperative anxiety)

**Computational Pharmacology**
- PK/PD modeling using machine learning approaches
- Drug-drug interaction prediction
- Population pharmacokinetics analysis

**Public Health Informatics**
- Epidemiological trend analysis and forecasting
- Health economics evaluation and cost-effectiveness modeling
- Disease burden assessment using global health data

---

## üìö Publications

### 2025

**Xu M**, **Liu H‚Ä†**, Dai A, et al. Dynamic and Interpretable Deep Learning Model for Predicting Respiratory Failure Following Cardiac Surgery. *BMC Anesthesiology*. 2025;25:239. [DOI: 10.1186/s12871-025-03239-z](https://doi.org/10.1186/s12871-025-03239-z)

Liu D, **Liu H**, Wu Y, Wang W. Time trends in stomach cancer mortality across the BRICS: An age-period-cohort analysis for the GBD 2021. *Front Public Health*. 2025;13:1506925. [DOI: 10.3389/fpubh.2025.1506925](https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1506925/full)

Zhang S, Tuerganbayi K, Wang J, **Liu H**, Shen P, Guo Y, et al. Incorporating preoperative and intraoperative data to predict postoperative pneumonia in elderly patients undergoing non-cardiothoracic surgery: The online two-stage prediction tool. *Geriatric Nursing*. 2025;62:244‚Äì253. [DOI: 10.1016/j.gerinurse.2025.02.012](https://www.sciencedirect.com/science/article/abs/pii/S019745722500076X?via%3Dihub)

### 2024

Dai A, **Liu H**, Shen P, et al. Incorporating preoperative frailty to assist in early prediction of postoperative pneumonia in elderly patients with hip fractures: an externally validated online interpretable machine learning model. *BMC Geriatrics*. 2024;24(1):472. [DOI: 10.1186/s12877-024-05050-w](https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-024-05050-w)

### 2023

**Liu H**, Dai A, Zhou Z, et al. An optimization for postpartum depression risk assessment and preventive intervention strategy based machine learning approaches. *Journal of Affective Disorders*. 2023;328:163-174. [DOI: 10.1016/j.jad.2023.02.028](https://www.sciencedirect.com/science/article/abs/pii/S0165032723001817?via%3Dihub) ‚≠ê **First Author**

---

## üéì Education

**Ph.D. in Pharmacokinetics and Drug Metabolism** | Sep 2024 ‚Äì Present  
State Key Laboratory of Natural Medicines, China Pharmaceutical University  
*Supervisors: Academician Guangji Wang (Principal, China Pharmaceutical University), Prof. Guo Yu (China Pharmaceutical University), Prof. De-chuan Zhan (Nanjing University)*  
*Focus: AI-driven drug discovery and computational pharmacokinetics*

**Master of Pharmacy (M.Pharm.)** | Sep 2021 ‚Äì Jun 2024  
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University  
*Supervisor: Associate Chief Pharmacist [Jianjun Zou](https://www.njsdyyy.com.cn/yiji/yaoxuebu/zhuanjiajieshao/2018-08-31/2668.html) (Nanjing First Hospital)*  
*Thesis: Machine learning applications in clinical pharmacy and perioperative risk prediction*

**B.Sc. in Clinical Pharmacy** | Sep 2016 ‚Äì Jun 2021  
Shenyang Pharmaceutical University

---

## üèÜ Awards & Honors

- **Outstanding Doctoral Student Scholarship**, China Pharmaceutical University, 2025
- **National Scholarship**, Ministry of Education of China, 2023
- **First Class Academic Scholarship**, China Pharmaceutical University, 2022, 2023
- **Suzhou Industrial Park Scholarship**, 2023

---

## üíª Technical Skills

**Programming & Data Science**  
Python (PyTorch, TensorFlow, scikit-learn), R (tidyverse, caret), MATLAB

**Machine Learning & AI**  
Deep Learning (CNNs, RNNs, Transformers, GNNs), Reinforcement Learning, Evolutionary Algorithms, Multi-objective Optimization, Generative Models (VAE, GAN, Diffusion Models)

**Bioinformatics & Computational Chemistry**  
RDKit, BioPython, Molecular Dynamics Simulations, Docking, Sequence Analysis

**Clinical Data Analysis**  
Survival Analysis, Longitudinal Data Modeling, Clinical Trial Design, Meta-analysis

**Tools & Platforms**  
Git, Docker, Linux/Unix, High-Performance Computing (HPC), Cloud Computing (AWS/Alibaba Cloud)

---

## üì∞ News & Updates

**December 2024**: Paper on dynamic respiratory failure prediction accepted by *BMC Anesthesiology*

**September 2024**: Started Ph.D. program at State Key Laboratory of Natural Medicines

**June 2024**: Graduated with Master of Pharmacy degree

**February 2023**: First-author paper on postpartum depression risk assessment published in *Journal of Affective Disorders*

---

## üîó Academic Profiles

- [Google Scholar](https://scholar.google.com/citations?hl=zh-CN&view_op=list_works&gmla=AC6lMd9ZAL7MD-yXOFnQmCFmWhCa7urnlogeAdo929JnzxRandLceciU-qudkLRbPcCzF0tvUz55S4B2e19h3nSeU5eG-u6rRUbmGGRFg4XK1bdWpqE4Xzs5yUVXtp85zI8&user=RYAl3IUAAAAJ)
- [ORCID](https://orcid.org/0000-0001-9627-6033)
- [GitHub](https://github.com/Harkool)
- [CNKI](https://au.cnki.net/author/personalInfo/000063918543)

---

## üìç Contact Information

**Email**: [3124074362@stu.cpu.edu.cn](mailto:3124074362@stu.cpu.edu.cn) | [lenhartkoo@foxmail.com](mailto:lenhartkoo@foxmail.com)

**Office**: A202, Yifu Building, Nanjing University Xianlin Campus  
163 Xianlin Avenue, Qixia District, Nanjing 210023, China  
Âçó‰∫¨Â∏ÇÊ†ñÈúûÂå∫‰ªôÊûóÂ§ßÈÅì163Âè∑, Âçó‰∫¨Â§ßÂ≠¶‰ªôÊûóÊ†°Âå∫, ÈÄ∏Â§´Ê•ºA202, 210023

**Mailing Address**: State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 211198, China

---

*Last updated: December 2024*
